-
[show abstract]
[hide abstract]
ABSTRACT: Cyclooxygenase-2 (COX-2) is thought to be linked to carcinogenesis; however, very little is known about its expression in pancreatic neoplasms. The authors studied the expression of COX-2 in human pancreatic neoplasms and investigated the effect of COX inhibitors on the growth of human pancreatic carcinoma cells.
Expression of COX-2 protein was immunohistochemically examined in 42 human pancreatic duct cell carcinomas (PDCs) and in 29 intraductal papillary mucinous tumors (IPMTs [adenomas, 19; carcinomas, 10]) of the pancreas that were resected surgically at the National Cancer Center Hospital in Tokyo. The growth of four human pancreatic carcinoma cell lines also was evaluated in the presence of COX inhibitors.
Marked COX-2 expression was observed in 57% (24 of 42) of PDCs, in 58% (11 of 19) of adenomas, and in 70% (7 of 10) of adenocarcinomas of IPMTs. However, there was no correlation between COX-2 expression and clinicopathologic indices of the patients. All four pancreatic cancer cell lines expressed COX-2 protein weakly or strongly, and the inhibitory effect of aspirin on cell growth was correlated with the expression of COX-2.
COX-2 was expressed in adenomas of IPMTs as well as in carcinomas and might have played a role in the development of pancreatic tumors. In this study, COX inhibitors, as nonsteroidal anti-inflammatory drugs, were shown to be possible preventive agents against pancreatic neoplasms.
Cancer 02/2001; 91(2):333-8. · 4.77 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The purposes of this study were to evaluate the long-term stability of a seasonal pattern of recurrent depression, identify possible factors associated with alteration of the seasonal pattern, and determine whether atypical vegetative symptoms during early seasonal depressive episodes predict future seasonal relapses.
The subjects were 41 patients satisfying the criteria used in the Japanese multicenter study of seasonal affective disorder who were consistently treated at the same outpatient clinic. Their longitudinal courses were evaluated by using case records and the Schedule for Affective Disorder and Schizophrenia--Life-time Version; the mean follow-up period was 10.4 years.
Nine subjects (22.0%) consistently showed a fall-winter pattern of recurrence throughout follow-up. Seventeen patients with an initial fall-winter pattern subsequently tended to shift seasons or show less seasonality. This alteration in pattern was possibly associated with antidepressant therapy or life events. Eleven patients with an initial diagnosis of nonseasonal affective disorder subsequently developed seasonal affective disorder; no specific factors were associated with this change. Atypical vegetative symptoms were significantly more common in patients with stable seasonal patterns of recurrence than in those who lost seasonality.
Although seasonal affective disorder appeared to be altered by antidepressant treatment, the presence of a core group of patients with a consistent seasonal pattern of recurrent depression suggests the validity of seasonal affective disorder as a distinct subtype of recurrent affective illness. The findings also suggest that atypical vegetative symptoms during early seasonal depressive episodes predict the subsequent seasonality of depression.
American Journal of Psychiatry 07/1995; 152(6):862-8. · 12.54 Impact Factor
-
The Japanese journal of psychiatry and neurology 07/1993; 47(2):470-2.
-
The Japanese journal of psychiatry and neurology 07/1993; 47(2):473-4.
-
[show abstract]
[hide abstract]
ABSTRACT: A nationwide survey of seasonal affective disorder (SAD) was performed from autumn 1990 to spring 1991 with the cooperation of 53 outpatient university psychiatric clinics in Japan. Forty-six SAD patients were identified among 5265 depressed outpatients. SAD was generally reported to occur in 1-3% of the depressed outpatients newly attending each facility. Hours of sunshine were found to be a more relevant variable influencing the prevalence of SAD than latitude or the mean temperature in December. The unexpectedly low percentage (20-30%) of SAD patients with atypical vegetative symptoms suggests that SAD patients who have no prior knowledge of SAD and those who are recruited via the media have different vegetative symptom profiles.
Acta Psychiatrica Scandinavica 05/1993; 87(4):258-65. · 4.22 Impact Factor
-
The Japanese journal of psychiatry and neurology 04/1992; 46(1):246-8.
